Article information
Full text is only aviable in PDF
Bibliografía
[1.]
D. Hoffmann, E.L. Wynder.
Chemical constituents and bioactivity of tobacco smoke.
Tobacco: a major international health hazard,
[2.]
B.J. Ingebrethsen.
Aerosol studies of cigarette smoke.
Recent Ad Tobacco Sci, 12 (1986), pp. 142
[3.]
US., Department of Health, Human Services, Public Health Service.
The Health Consequences of smoking: Cancer.
A Report of the Surgeon General. DHHS (CDC) Publication N. ° 82-50179, US Government Printing Office, (1982),
[4.]
N.L. Benowitz.
Pharmacokinetic considerations m understanding nicotine dependence. The biology of nicotine dependence.
Wiley Chichester (Ciba Foundation Symposium 152), (1990), pp. 186-209
[5.]
H. Schievelbein.
Nicotina. En: Enciclopedia de Salud y Seguridad en el Trabajo.
L Parmeggiani, eds. Centro de Publicaciones del Ministerio de Trabajo y Seguridad Social, (1989), pp. 1. 625-1. 626
[6.]
J. Le Houezec, N.L. Benowitz.
Basic clinical psychopharmacology of nicotine.
Clinics in Chest Medicine, pp. 681-699
[7.]
N.L. Benowitz.
Pharmacokinetics and pharmacodynamics of nicotine.
pp. 3-18
[8.]
W.W. Mapleson.
Circulation-time models of the uptake of inhaled anesthesics and data for quantifying them.
Br J Anaesth, 45 (1973), pp. 319-334
[9.]
M. Curvall, C.R. Enzell.
Monitoring absorption by means of determination of nicotine and cotinine.
Arch Toxicol, 9 (1986), pp. 88-102
[10.]
C. Izard.
Neuropsychologie du tabac.
Masson et Cie, (1976),
[11.]
M.J. Rand.
Neuropharmacological effeets of nicotine in relation to cholinergic mechanisms.
Progress in Brain Research: Nicotinic receptors in the CNS, their role in synaptic transmission. Amsterdam:, pp. 3-11
[12.]
N.L. Benowitz, H. Porchet, J. Peyton.
Pharmacokinetics metabolism and pharmacodynamics of nicotine.
pp. 112-157
[13.]
N.L. Benowitz.
Tabaquismo de cigarrillos y adicción a la nicotina.
Tabaquismo de cigarrillos: Guía clínica para la valoración y el tratamiento. Clínicas Médicas de Norteamérica, pp. 409-433
[14.]
M.A. Russell.
Subjective and behavioural effects of nicotine in humans: some sources of individual variation.
pp. 289-301
[15.]
O.F. Pomerleau.
Nicotine and the central nervous System: Biobehavioral effeets of cigarette smoking.
Am J Med, 93 (1992), pp. 2-7
[16.]
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed.
(3., a, ed., revisada), American Psychiatric Association, (1978),
[17.]
A.H. Beckett.
A possible relation between pKa, and lipid solubility and the amounts excreted in uriñe of some tobacco alkaloids given to man.
J Pharm Pharmacol, 24 (1972), pp. 115-120
[18.]
L. Miller.
Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics.
Clin Pharmacokinet, 17 (1989), pp. 90-108
[19.]
US., Department of Health, Human Services, Public Health Service.
The Health Consequences of Smoking: Nicotine Addiction.
A Report of the Surgeon General. DHHS (CDC) Publication N. ° 88-8406, US Government Printing Office, (1988),
[20.]
W.A. Hunt, L.W. Barnett.
Relapse rates in addiction programs.
J Clin Psychol, 27 (1971), pp. 455
[21.]
C. Cohen, W.B. Pickworth, J.E. Henningfield.
Cigarette smoking and addiction.
Smoking cessation. Clinics in Chest Medicine, pp. 701-710
[22.]
E.B. Fisher, D. Haire-Joshu, G.D. Morgan, et al.
State of the Art: Smoking and Smoking cessation.
Am Rev Respir Dis, 142 (1990), pp. 702-720
[23.]
K.O. Fargerstrom.
Tobacco smoking, nicotine dependence and smoking cessation.
Acta Univ Upsaliensis, (1981),
Copyright © 1995. Sociedad Española de Neumología y Cirugía Torácica
